Notably, all three YAP1/WWTR1 compensable cell lines (BICR10, HSC-2 and HSC-4) harbor PIK3CA mutation, and that alterations in the PI3K signaling pathway have been linked to multiple metabolic dysregulations in cancer (Hao et al., 2016). Here, WWTR1 is linked to cancer.